The Promoting Access and Care through Centres of Excellence (PACE) network brings together leading inflammatory bowel disease (IBD) centres to advance best practices for medical professionals and elevate the standard of care for patients in Canada with IBD.
Launched in 2016, PACE is Canada’s first national network of IBD Centres of Excellence. Through collaborative research efforts between the centres, the network aims to address existing gaps in how people with Crohn’s disease or ulcerative colitis access care. Evidence gathered through research and clinical care will be the catalyst for changes in the public healthcare system.
Request for Applications
In phase two of the PACE program, Crohn’s and Colitis Canada will launch priority-driven research programs that address gaps in care in the following areas for IBD patients in Canada:
1) Mental health; and
2) Diet and nutrition
The initiatives must be developed and pilot tested over a three-year period with the potential for national dissemination, and be recognized as a significant advancement in the quality of IBD healthcare delivery in Canada.
To learn more about the Request for Applications or to submit a Notice of Intent to Apply click here.
What is an IBD Centre of Excellence?
To receive optimal care for Crohn’s or colitis, patients require a multidisciplinary team. When that team of specialists is scattered at various sites, it makes it difficult for patients to coordinate multiple visits and have their multi-faceted needs met.
For the PACE network, an IBD Centre of Excellence houses a team of medical professionals skilled in various areas to provide more complete care to people with Crohn’s or colitis. PACE sites provide leadership, research, and training for IBD care.
Servicing remote communities through telemedicine
This initiative out of Toronto’s Mount Sinai Hospital looks to extend specialized Crohn’s and colitis care to underserved communities. Dr. Geoff Nguyen and his team have identified geographic regions across Canada where people with IBD have difficulty accessing specialized care.
The team at Mount Sinai Hospital are expanding telemedicine accessibility to patients through nurses who specialize in treating IBD while utilizing existing provincial telemedicine infrastructure. A clinical trial evaluating telemedicine offerings is underway in Ontario with a view to expand the program across the country.
Learn more about Mount Sinai’s PACE IBD telemedicine program
Learn more about the Ontario Telemedicine Network
Monitoring patient health between visits
Dr. John Marshall and Dr. Neeraj Narula at McMaster University in Hamilton are helping patients take a more active role in their healthcare by implementing a tool that allows patients and healthcare teams to better monitor the patients’ disease between planned visits. The electronic reporting tool also gives healthcare providers more robust information during visits with patients.
Once the reporting tool is piloted, it will be integrated into clinical care practices at other PACE centres, and work in tandem with the telemedicine program noted above.
Reducing chronic steroid use
People with Crohn’s or colitis are often prescribed steroids to control their symptoms. While this treatment can be effective at relieving symptoms, it carries the potential for a number of short and long-term side effects.
Dr. Karen Kroeker, Dr. Remo Panaccione, and Dr. Cynthia Seow at the University of Alberta and the University of Calgary are developing and implementing a clinical care pathway that offers healthcare providers guidelines on how to limit or avoid steroid use. The clinical care pathway will be integrated into clinical practices across PACE sites, and then nationally, to standardize care for IBD patients and reduce chronic steroid use.
Measuring healthcare advances
Dr. Alain Bitton and Dr. Waqqas Afif at McGill University in Montreal are establishing quality indicators, based on current evidence and patient input, that will measure the effectiveness of PACE initiatives and other IBD quality improvement programs.
Additionally, the PACE team are collaborating with Crohn’s and colitis specialists to develop and implement a web-based, quality improvement self-assessment tool to identify gaps in care, change the focus to patient centred care delivery, and standardize care on a national level. It is an innovative model designed to improve quality of care by establishing standardized and, where possible, evidence-based milestones and self-assessment metrics for ongoing quality improvement activities for IBD clinics and healthcare professionals.
Development of a Global Rating Scale for Inflammatory Bowel Disease
Access to Specialists and Emergency Department Visits in Inflammatory Bowel Disease
Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives
Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
PACE marks its second year with further progress in raising the standards of Crohn’s and colitis care
PACE program adds a new partner in Thunder Bay
PACE program adds new site co-lead in Calgary
The progress of PACE, one year after launch
Bringing care closer to people with Crohn’s or colitis
New Crohn's and Colitis Canada Network Unites World-Class Canadian Healthcare Centres
Terms of Reference
Please find below the Promoting Access and Care Through Centres of Excellence (PACE) Terms of Reference, which will provide you with more information about the roles and responsibilities of our Steering and Oversight Committees. In addition, you will find a list of the current membership.
Terms of Reference
Strengthen the PACE network
Donations to Crohn’s and Colitis Canada allow the PACE network to carry on its vital work and elevate inflammatory bowel disease care. Click here to make a donation. To find out more about how you can contribute to PACE, contact Katy Devitt, Manager of Research Programs at Crohn’s and Colitis Canada.